Capital raised by Cynaptec Pharmaceuticals
1 Form D filing · first filed Apr 2025 · Stuart, FL
Chief Executive Officer
Signatory on Cynaptec Pharmaceuticals's Form D filings · $6.0M raised across 1
Frederick Sancilio is on file as Chief Executive Officer at Cynaptec Pharmaceuticals in Stuart, FL. Cynaptec Pharmaceuticals has 1 Form D filing on record, $6.0M raised in total. Frederick Sancilio appears as a signatory on the company's filings.
Conjugated Psilocin™ is a patented, oral, and stable analog of psilocin, which is the active metabolite of psilocybin. This compound has been engineered for enhanced stability and bioavailability, making it more suitable for clinical use compared to traditional psilocin formulations.
